Raymond J. Lipicky

1.7k total citations
48 papers, 1.3k citations indexed

About

Raymond J. Lipicky is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Raymond J. Lipicky has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Raymond J. Lipicky's work include Cardiac electrophysiology and arrhythmias (10 papers), Ion channel regulation and function (8 papers) and Neuroscience and Neural Engineering (6 papers). Raymond J. Lipicky is often cited by papers focused on Cardiac electrophysiology and arrhythmias (10 papers), Ion channel regulation and function (8 papers) and Neuroscience and Neural Engineering (6 papers). Raymond J. Lipicky collaborates with scholars based in United States, Peru and Italy. Raymond J. Lipicky's co-authors include S. H. Bryant, Daniel L. Gilbert, Udho Thadani, Robert R. Fenichel, Dan M. Roden, Louis R. Cantilena, Charles Antzelevitch, Silvia G. Priori, Michael C. Sanguinetti and Marek Malík and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Raymond J. Lipicky

48 papers receiving 1.1k citations

Peers

Raymond J. Lipicky
Anthony A. Fossa United States
David J. Gallacher Belgium
Benoît Drolet Canada
Richard Anziano United States
William F. Ebling United States
Céline Fiset Canada
B. Waeber Switzerland
William Crumb United States
J M Ritter United Kingdom
W. J. Louis Australia
Anthony A. Fossa United States
Raymond J. Lipicky
Citations per year, relative to Raymond J. Lipicky Raymond J. Lipicky (= 1×) peers Anthony A. Fossa

Countries citing papers authored by Raymond J. Lipicky

Since Specialization
Citations

This map shows the geographic impact of Raymond J. Lipicky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond J. Lipicky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond J. Lipicky more than expected).

Fields of papers citing papers by Raymond J. Lipicky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond J. Lipicky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond J. Lipicky. The network helps show where Raymond J. Lipicky may publish in the future.

Co-authorship network of co-authors of Raymond J. Lipicky

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond J. Lipicky. A scholar is included among the top collaborators of Raymond J. Lipicky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond J. Lipicky. Raymond J. Lipicky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zannad, Faı̈ez, Wendy Gattis Stough, Raymond J. Lipicky, et al.. (2016). Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion. European Heart Journal - Cardiovascular Pharmacotherapy. 2(3). 200–205. 20 indexed citations
2.
Glasser, Stephen P., James Willard, Albert DeFelice, et al.. (2011). Is Randomization to Placebo Safe? Risk in Placebo-Controlled Angina Trials: Angina Risk Meta-Analysis. Cardiology. 120(3). 174–181. 1 indexed citations
3.
Cushing, Daniel J., et al.. (2009). PM101: A cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effects. European Journal of Pharmacology. 607(1-3). 167–172. 23 indexed citations
4.
Cushing, Daniel J., et al.. (2009). Evaluation of the Effects of PM101, a Cyclodextrin-Based Formulation of Intravenous Amiodarone, on Blood Pressure in Healthy Humans. The American Journal of Cardiology. 104(8). 1152–1157. 8 indexed citations
5.
Cushing, Daniel J., et al.. (2009). Comparison of the Cardiac Electrophysiology and General Toxicology of Two Formulations of Intravenous Amiodarone in Dogs. Cardiovascular Toxicology. 9(3). 126–133. 10 indexed citations
6.
Cushing, Daniel J., et al.. (2009). Bioequivalence of 2 Intravenous Amiodarone Formulations in Healthy Participants. The Journal of Clinical Pharmacology. 49(4). 407–415. 10 indexed citations
7.
DeFelice, Albert, James Willard, John Lawrence, et al.. (2008). The risks associated with short-term placebo-controlled antihypertensive clinical trials: a descriptive meta-analysis. Journal of Human Hypertension. 22(10). 659–668. 14 indexed citations
8.
Myers, Martin G. & Raymond J. Lipicky. (2001). Assessment of antihypertensive activity in the regulatory setting. Blood Pressure Monitoring. 6(6). 309–312. 4 indexed citations
9.
O'Brien, E T, Gert van Montfrans, Paolo Palatini, et al.. (2001). Task Force I: Methodological aspects of blood pressure measurement. Blood Pressure Monitoring. 6(6). 313–315. 5 indexed citations
10.
Fleming, Thomas, Jeffrey Borer, Raymond J. Lipicky, & Paul W. Armstrong. (2001). Report from the 94th Cardiovascular and Renal Drugs Advisory Committee Meeting, October 11, 2001. Circulation. 104(18). E9039–E9039. 1 indexed citations
11.
Lipicky, Raymond J.. (2000). An FDA perspective on antiarrhythmic drugs in phase II trials. American Heart Journal. 139(4). S197–S199. 2 indexed citations
12.
Kraeling, Margaret E. K., Raymond J. Lipicky, & Robert L. Bronaugh. (1996). Metabolism of Benzocaine during Percutaneous Absorption in the Hairless Guinea Pig: Acetylbenzocaine Formation and Activity. Skin Pharmacology and Physiology. 9(3). 221–230. 11 indexed citations
13.
Thadani, Udho & Raymond J. Lipicky. (1994). Short and long-acting oral nitrates for stable angina pectoris. Cardiovascular Drugs and Therapy. 8(4). 611–623. 41 indexed citations
14.
Thadani, Udho & Raymond J. Lipicky. (1994). Ointments and transdermal nitroglycerin patches for stable angina pectoris. Cardiovascular Drugs and Therapy. 8(4). 625–633. 27 indexed citations
15.
Lipicky, Raymond J. & Milton Packer. (1993). Role of surrogate end points in the evaluation of drugs for heart failure. Journal of the American College of Cardiology. 22(4). A179–A184. 35 indexed citations
16.
Lipicky, Raymond J.. (1993). A viewpoint on drugs that prolong the QTc interval. The American Journal of Cardiology. 72(6). B53–B54. 18 indexed citations
17.
Fishman, Harvey M. & Raymond J. Lipicky. (1991). Determination of K+-channel relaxation times in squid axon membrane by Hodgkin-Huxley and by direct linear analysis. Biophysical Chemistry. 39(2). 177–190. 3 indexed citations
18.
Lipicky, Raymond J., Daniel L. Gilbert, & Gerald Ehrenstein. (1978). Effects of yohimbine on squid axons. Biophysical Journal. 24(2). 405–422. 22 indexed citations
19.
20.
Lipicky, Raymond J. & S. H. Bryant. (1966). Sodium, Potassium, and Chloride Fluxes in Intercostal Muscle from Normal Goats and Goats with Hereditary Myotonia. The Journal of General Physiology. 50(1). 89–111. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony A. Fossa Breakdown of academic impact, for papers by David J. Gallacher Breakdown of academic impact, for papers by Benoît Drolet Breakdown of academic impact, for papers by Richard Anziano Breakdown of academic impact, for papers by William F. Ebling Breakdown of academic impact, for papers by Céline Fiset Breakdown of academic impact, for papers by B. Waeber Breakdown of academic impact, for papers by William Crumb Breakdown of academic impact, for papers by J M Ritter Breakdown of academic impact, for papers by W. J. Louis
Rankless by CCL
2026